JP2023503455A5 - - Google Patents

Info

Publication number
JP2023503455A5
JP2023503455A5 JP2022529681A JP2022529681A JP2023503455A5 JP 2023503455 A5 JP2023503455 A5 JP 2023503455A5 JP 2022529681 A JP2022529681 A JP 2022529681A JP 2022529681 A JP2022529681 A JP 2022529681A JP 2023503455 A5 JP2023503455 A5 JP 2023503455A5
Authority
JP
Japan
Prior art keywords
capsid protein
modified
seq
targeting peptide
different brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022529681A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023503455A (ja
JP7712271B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/061464 external-priority patent/WO2021102234A1/en
Publication of JP2023503455A publication Critical patent/JP2023503455A/ja
Publication of JP2023503455A5 publication Critical patent/JP2023503455A5/ja
Priority to JP2025044678A priority Critical patent/JP7888221B2/ja
Priority to JP2025116303A priority patent/JP2025148448A/ja
Application granted granted Critical
Publication of JP7712271B2 publication Critical patent/JP7712271B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022529681A 2019-11-22 2020-11-20 アデノ随伴ウイルスベクター変種 Active JP7712271B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2025044678A JP7888221B2 (ja) 2019-11-22 2025-03-19 アデノ随伴ウイルスベクター変種
JP2025116303A JP2025148448A (ja) 2019-11-22 2025-07-10 アデノ随伴ウイルスベクター変種

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962939315P 2019-11-22 2019-11-22
US62/939,315 2019-11-22
US202063084709P 2020-09-29 2020-09-29
US63/084,709 2020-09-29
PCT/US2020/061464 WO2021102234A1 (en) 2019-11-22 2020-11-20 Adeno-associated viral vector variants

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2025044678A Division JP7888221B2 (ja) 2019-11-22 2025-03-19 アデノ随伴ウイルスベクター変種
JP2025116303A Division JP2025148448A (ja) 2019-11-22 2025-07-10 アデノ随伴ウイルスベクター変種

Publications (3)

Publication Number Publication Date
JP2023503455A JP2023503455A (ja) 2023-01-30
JP2023503455A5 true JP2023503455A5 (cg-RX-API-DMAC7.html) 2024-01-30
JP7712271B2 JP7712271B2 (ja) 2025-07-23

Family

ID=75980202

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2022529681A Active JP7712271B2 (ja) 2019-11-22 2020-11-20 アデノ随伴ウイルスベクター変種
JP2025044678A Active JP7888221B2 (ja) 2019-11-22 2025-03-19 アデノ随伴ウイルスベクター変種
JP2025116303A Pending JP2025148448A (ja) 2019-11-22 2025-07-10 アデノ随伴ウイルスベクター変種

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2025044678A Active JP7888221B2 (ja) 2019-11-22 2025-03-19 アデノ随伴ウイルスベクター変種
JP2025116303A Pending JP2025148448A (ja) 2019-11-22 2025-07-10 アデノ随伴ウイルスベクター変種

Country Status (13)

Country Link
US (2) US12653910B2 (cg-RX-API-DMAC7.html)
EP (1) EP4061427A4 (cg-RX-API-DMAC7.html)
JP (3) JP7712271B2 (cg-RX-API-DMAC7.html)
KR (1) KR102997604B1 (cg-RX-API-DMAC7.html)
CN (2) CN115023242B (cg-RX-API-DMAC7.html)
AU (1) AU2020388404A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022009864A2 (cg-RX-API-DMAC7.html)
CA (1) CA3159113A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022008507A2 (cg-RX-API-DMAC7.html)
IL (1) IL293140A (cg-RX-API-DMAC7.html)
MX (1) MX2022006188A (cg-RX-API-DMAC7.html)
PH (1) PH12022551247A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021102234A1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL297237B2 (en) * 2020-04-17 2025-08-01 Regeneron Pharma Detection assays for coronavirus neutralizing antibodies
KR20240095539A (ko) 2021-10-08 2024-06-25 디노 테라퓨틱스, 인코포레이티드 캡시드 변이체 및 이의 사용 방법
JP2025514794A (ja) * 2022-04-22 2025-05-09 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア ヒト上衣特異的プロモーターおよびその使用方法
EP4522272A4 (en) * 2022-05-11 2026-07-29 Childrens Hospital Philadelphia Adeno-associated viral vectors to target deep brain structures
JP2025516715A (ja) * 2022-05-13 2025-05-30 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア 脳微小血管系を標的とするアデノ随伴ウイルスベクター
CN119213120A (zh) 2022-05-16 2024-12-27 建新公司 治疗异染性脑白质营养不良的方法
WO2024017387A1 (en) * 2022-07-22 2024-01-25 Shanghai Vitalgen Biopharma Co., Ltd. Novel aav capsids for targeting nervous system and uses thereof
KR102870168B1 (ko) * 2022-08-26 2025-10-13 김선아 활막 표적화 화합물 및 이의 용도
CN120187459A (zh) * 2022-09-19 2025-06-20 费城儿童医院 使用split-seq在单细胞分辨率下的aav进化
IL322459A (en) * 2023-01-31 2025-09-01 Childrens Hospital Philadelphia Innovative gene therapy construct for cln2 disease
JP2026509271A (ja) 2023-03-10 2026-03-17 ダイノ セラピューティクス,インコーポレーテッド カプシドポリペプチドおよびその使用方法
CN117964715B (zh) * 2023-07-21 2025-01-24 广州派真生物技术有限公司 腺相关病毒突变体及其应用
KR20260082361A (ko) 2023-08-31 2026-06-04 디노 테라퓨틱스, 인코포레이티드 캡시드 폴리펩타이드 및 이의 사용 방법
WO2025090631A1 (en) * 2023-10-23 2025-05-01 The Children's Hospital Of Philadelphia Aav vectors for delivery of apoe2
CN122319003A (zh) * 2023-10-23 2026-06-30 费城儿童医院 用于治疗cln2疾病的aav载体
AR134407A1 (es) * 2023-11-15 2026-01-14 Genzyme Corp Métodos de tratamiento de la enfermedad de gaucher y de la enfermedad de parkinson gba
CN122206466A (zh) * 2023-11-15 2026-06-12 建新公司 治疗神经变性障碍的方法
TW202545971A (zh) 2024-02-08 2025-12-01 美商戴諾治療公司 殼體多肽及其使用方法
WO2025213097A1 (en) * 2024-04-05 2025-10-09 The Children's Hospital Of Philadelphia Novel gene therapy constructs for stxbp1 haploinsufficiency
WO2025231406A1 (en) * 2024-05-02 2025-11-06 The Children's Hospital Of Philadelphia Methods to increase transduction of ependyma cells in brain
WO2026052039A1 (en) * 2024-09-06 2026-03-12 Sichuan Real & Best Biotech Co., Ltd. Engineered adeno-associated virus capsid protein and the use thereof
WO2026064442A2 (en) 2024-09-18 2026-03-26 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
WO2026122963A1 (en) 2024-12-06 2026-06-11 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
WO2026165267A1 (en) * 2025-01-31 2026-08-06 Genzyme Corporation Methods of treating neurodegenerative disorders
CN121265801A (zh) * 2025-06-06 2026-01-06 昆明理工大学 一种靶向性的药物递送载体及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040031072A1 (en) * 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
DK2359869T3 (en) 2001-12-17 2019-04-15 Univ Pennsylvania Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
WO2006105392A2 (en) 2005-03-30 2006-10-05 The Cleveland Clinic Foundation Neuron targeting peptides
CA2693712C (en) 2007-07-14 2018-05-29 The University Of Iowa Research Foundation Methods and compositions for treating brain diseases
WO2011119484A1 (en) 2010-03-23 2011-09-29 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
US10738326B2 (en) 2010-10-27 2020-08-11 Jichi Medical University Adeno-associated virus vector for gene transfer to nervous system cells
EP3564379A1 (en) 2013-09-13 2019-11-06 California Institute of Technology Selective recovery
DE102014207498A1 (de) * 2014-04-17 2015-10-22 Universitätsklinikum Hamburg-Eppendorf Viraler Vektor für den zielgerichteten Gentransfer in Gehirn und Rückenmark
AU2015349759B2 (en) 2014-11-21 2022-01-06 The University Of North Carolina At Chapel Hill Aav vectors targeted to the central nervous system
CA2977355A1 (en) 2015-02-20 2016-08-25 University Of Iowa Research Foundation Methods and compositions for treating genetic eye diseases
AU2016366549B2 (en) 2015-12-11 2022-11-10 California Institute Of Technology Targeting peptides for directing adeno-associated viruses (AAVs)
CN109640949B (zh) 2016-07-29 2022-11-25 加利福尼亚大学董事会 具有变异衣壳的腺相关病毒病毒体和其使用方法
EP3583220A4 (en) 2017-02-15 2021-07-07 The University of North Carolina at Chapel Hill PROCEDURES AND COMPOSITIONS FOR GENERAL TRANSFER IN THE VASCULAR SYSTEM
MX2019013528A (es) * 2017-05-12 2020-07-14 The Children´S Hospital Of Philadelphia Variantes de sulfamidasa (sgsh) y vectores, composiciones, metodos y usos para tratar la mucopolisacaridosis tipo iiia (mps iiia).
DK3684423T5 (da) * 2017-09-20 2024-08-26 4D Molecular Therapeutics Inc Adeno-associerede virusvariantcapsider og fremgangsmåder til anvendelse deraf
MX2020003042A (es) * 2017-09-29 2020-11-18 Voyager Therapeutics Inc Rescate del fenotipo neurológico central y periférico de la ataxia de friedreich mediante administración intravenosa.
WO2019113538A2 (en) 2017-12-07 2019-06-13 California Institute Of Technology Methods and systems for noninvasive control of brain cells and related vectors and compositions
WO2019222329A1 (en) 2018-05-15 2019-11-21 Voyager Therapeutics, Inc. Compositions and methods for delivery of aav
JP2021530218A (ja) * 2018-07-11 2021-11-11 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. 血液脳関門を超える薬剤の送達のための方法および組成物
CN115605596A (zh) 2020-02-12 2023-01-13 费城儿童医院(Us) 用于基因表达的诱导型可变剪接调节的组合物和方法

Similar Documents

Publication Publication Date Title
JP2021534809A (ja) Aavカプシドの向性の再指向化
JP2024540221A (ja) Aavカプシドバリアント及びその使用
WO2023235791A1 (en) Aav capsid variants and uses thereof
KR20190117571A (ko) 혈관계를 통한 유전자 전달 방법 및 조성물
JP2022066336A5 (cg-RX-API-DMAC7.html)
JP2022545226A5 (cg-RX-API-DMAC7.html)
JP2020500526A5 (cg-RX-API-DMAC7.html)
JP2023535576A5 (cg-RX-API-DMAC7.html)
WO2021031810A1 (zh) Ptbp1抑制剂在预防和/或治疗功能性神经元死亡相关的神经系统疾病中的应用
WO2022033454A1 (en) Compositions and methods for dissolving protein aggregates
JP2025516583A5 (cg-RX-API-DMAC7.html)
WO2023212694A2 (en) Compositions comprising aav-binding polypeptides and methods of using the same
JP2023544141A (ja) AIMP2-DX2および必要に応じてmiR-142の標的配列ならびにその組成物を使用した神経系疾患を処置する方法
JP2024515902A5 (cg-RX-API-DMAC7.html)
JP2020533968A (ja) 組換えアデノ随伴ベクター
JP2022533451A5 (cg-RX-API-DMAC7.html)
JP2023505271A5 (cg-RX-API-DMAC7.html)
WO2021032068A1 (zh) Ptbp1抑制剂在预防和/或治疗功能性神经元死亡相关的神经系统疾病中的应用
JP2025516136A (ja) 神経変性疾患の治療のための組み換えaavベクター
JP2022530168A5 (cg-RX-API-DMAC7.html)
Bouju et al. Molecular cloning and functional expression of a novel human gene encoding two 41–43 kDa skeletal muscle internal membrane proteins
CN117916365A (zh) 用于治疗结晶样视网膜变性的重组腺相关病毒载体
JP2024521401A5 (cg-RX-API-DMAC7.html)
JP2023538130A5 (cg-RX-API-DMAC7.html)
JP2024505197A5 (cg-RX-API-DMAC7.html)